Editorial
doi: 10.1016/j.jhep.2006.02.002.
Epub 2006 Feb 17.
Immunosuppression and outcomes of patients transplanted for hepatitis C
- PMID: 16503080
- DOI: 10.1016/j.jhep.2006.02.002
Item in Clipboard
Editorial
Immunosuppression and outcomes of patients transplanted for hepatitis C
J Hepatol.
2006 Apr.
No abstract available
Comment on
-
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.J Hepatol. 2006 Apr;44(4):702-9. doi: 10.1016/j.jhep.2005.11.047. Epub 2006 Jan 4. J Hepatol. 2006. PMID: 16473433 Clinical Trial.
-
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study.J Hepatol. 2006 Apr;44(4):710-6. doi: 10.1016/j.jhep.2005.12.010. Epub 2006 Jan 24. J Hepatol. 2006. PMID: 16487622 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
